Curanex Pharmaceuticals
CURX
8 hedge funds and large institutions have $168K invested in Curanex Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.
19% more capital invested
Capital invested by funds: $140K → $168K (+$27.1K)
0.34% less ownership
Funds ownership: 1.5% → 1.16% (-0.34%)
27% less funds holding
Funds holding: 11 → 8 (-3)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$34.7K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$21.3K |
| 3 |
Citigroup
New York
|
+$7.26K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$3.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$23.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$20.2K |
| 3 |
Renaissance Technologies
New York
|
-$19.6K |
| 4 |
Two Sigma Investments
New York
|
-$15.3K |
| 5 |
Jane Street
New York
|
-$8.26K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $56.8K | +$34.7K | +92,460 | +495% |
|
|
TSS
2
Two Sigma Securities
New York
| $29K | +$21.3K | +56,651 | New |
|
|
XT
3
XTX Topco
George Town,
Cayman Islands
| $26.2K | +$3.34K | +8,904 | +21% |
|
|
4
Citadel Advisors
Miami,
Florida
| $25.9K | -$20.2K | -53,719 | -52% |
|
|
5
Two Sigma Investments
New York
| $10.4K | -$15.3K | -40,848 | -67% |
|
|
6
Citigroup
New York
| $9.88K | +$7.26K | +19,332 | New |
|
|
JF
7
Jump Financial
Chicago,
Illinois
| $5.39K | -$2.59K | -6,900 | -40% |
|
8
UBS Group
Zurich,
Switzerland
| $4.08K | -$1.88K | -4,996 | -38% |
|
|
DS
9
DRW Securities
Chicago,
Illinois
| – | -$23.7K | -71,553 | Closed |
|
|
10
Renaissance Technologies
New York
| – | -$19.6K | -59,297 | Closed |
|
|
11
Jane Street
New York
| – | -$8.26K | -24,990 | Closed |
|
|
HF
12
HRT Financial
New York
| – | -$4K | -12,378 | Closed |
|
13
Bank of America
Charlotte,
North Carolina
| – | -$11 | -34 | Closed |
|
CURX Hedge Fund Activity: Q1 2026 in Review
8 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Curanex Pharmaceuticals (CURX) for Q1 2026, worth a combined $168K — up 19% from $140K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CURX and 2 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was Geode Capital Management, adding an estimated $34.7K. The largest seller was DRW Securities, exiting entirely with an estimated $23.7K sold.
- 8 institutional investors held Curanex Pharmaceuticals (CURX) as of Q1 2026, down from 11 in Q4 2025.
- Funds reported $168K of Curanex Pharmaceuticals stock for Q1 2026, up 19% quarter-over-quarter.
- 2 funds opened new Curanex Pharmaceuticals positions in Q1 2026 and 5 closed out, a net change of -3 holders.
- The largest Curanex Pharmaceuticals buyer in Q1 2026 was Geode Capital Management, an estimated $34.7K added.
- The largest Curanex Pharmaceuticals seller in Q1 2026 was DRW Securities, an estimated $23.7K sold.
Based on aggregated 13F filings for Q1 2026.